KRRO vs KTTA

Korro Bio, Inc. vs Pasithea Therapeutics Corp. — Valuation Comparison 2026

KRRO

Pharmaceutical Preparations
Korro Bio, Inc.
Quality
5.1
out of 10
Value Trap
28
LOW
Price
$13.41
Last close
Models
9/13
Active
VS

KTTA

Pharmaceutical Preparations
Pasithea Therapeutics Corp.
Quality
4.1
out of 10
Value Trap
24
SAFE
Price
$0.72
Last close
Models
7/13
Active

Model-by-Model Comparison

ModelType KRRO Fair ValueKRRO Upside KTTA Fair ValueKTTA Upside
Bayesian DCF Intrinsic $3.85 -71.3% $1.30 +81.5%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $9.46 -29.4% $2.30 +222.0%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for KRRO vs KTTA — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

KRRO vs KTTA — Which Stock Is More Undervalued?

KRRO scores higher with a 5.1/10 quality rating vs KTTA's 4.1/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Korro Bio, Inc. (KRRO) and Pasithea Therapeutics Corp. (KTTA) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

KRRO currently trades at $13.41 with a QOC of 5.1/10, while KTTA trades at $0.72 with a QOC of 4.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).